Anazao Health Recalls Morphine, Fentanyl, and Baclofen Due to Fungal Contamination
Coast Quality Pharmacy, LLC dba Anazao Health is recalling Morphine Sulfate, Fentanyl Citrate, and Baclofen products due to the detection of Talaromyces rotundus fungi.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses or injuries, and the hazard is a low-level fungal contamination (1 CFU) without explicit high-risk pathogen designation, fitting the criteria for a moderate, precautionary recall.
Plain-English summary
Coast Quality Pharmacy, LLC dba Anazao Health is recalling Morphine Sulfate and Fentanyl Citrate and Baclofen in all strengths, doses, and packaging. The recall is being conducted because environmental sampling revealed the presence of Talaromyces rotundus, a type of fungi, indicating a lack of processing controls.
The affected products were filled on August 26, 2019, and dispensed between August 26 and August 29, 2019. The recall covers all lots remaining within their expiration dates. Distribution was nationwide in the U.S.
Consumers who have these products should stop using them and contact their healthcare provider or pharmacist for further instructions.
The recalled product
- Product
- Morphine Sulfate and Fentanyl Citrate and Baclofen in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.
- Manufacturer
- Coast Quality Pharmacy, LLC dba Anazao Health
- Category
- Drug — Pharmacy Compounded
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots filled 08/26/2019 and dispensed 08/26-29/2019 remaining within expiry.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 31 recalled by Coast Quality Pharmacy, LLC dba Anazao Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 31 products in this recall →Related recalls
Same manufacturer · Coast Quality Pharmacy, LLC dba Anazao Health
See all →- HighProgesterone 200 mg compounded tablets recalled for embedded metal fragments
FDA (Drugs) · 2024-07-03
- ModerateAnazao Health Recalls Clonidine and Hydromorphone Due to Fungal Contamination
FDA (Drugs) · 2019-12-18
- SevereAnazao Health Recalls Hydromorphone, Baclofen, and Clonidine Combination Drugs
FDA (Drugs) · 2019-12-18
- SevereAnazao Health Recalls Compounded Sufentanil Syringes Due to Fungal Contamination
FDA (Drugs) · 2019-12-18
- SevereAnazao Health Recalls Baclofen, Clonidine, and Morphine Sulfate Due to Fungal Contamination
FDA (Drugs) · 2019-12-18
Same hazard · fungal contamination
See all →- CriticalMedline Convenience Kits Recalled for Fungal Contamination Risk
FDA (Devices) · 2026-09-23
- CriticalMedline Convenience Kits Recalled for Potential Fungal Contamination
FDA (Devices) · 2026-09-23
- SevereMedline Convenience Kits Recalled for Fungal Contamination Risk
FDA (Devices) · 2026-09-23
- CriticalMedline Convenience Kits Recalled for Potential Fungal Contamination
FDA (Devices) · 2026-09-23
- CriticalMedline Recalls Blood and Urine Collection Kits Due to Fungal Contamination
FDA (Devices) · 2026-09-23
Similar recalls
- SevereFDA Recalls Compounded Morphine, Fentanyl, and Baclofen Injection for Sterility Concerns
FDA (Drugs) · 2015-09-23
- SeverePharmedium Recalls Fentanyl and Bupivacaine Injections Due to Sterility Concerns
FDA (Drugs) · 2018-02-28
- SevereFDA Recalls Compounded Morphine and Fentanyl Solution Due to Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereFDA Recalls Hydromorphone and Baclofen Intrathecal Solution Due to Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereFDA Recalls Compounded Intrathecal Solution Due to Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereFDA Recalls Intrathecal Solution Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23